{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:43:24Z","timestamp":1761129804420},"reference-count":32,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2020,9,29]]},"DOI":"10.1536\/ihj.20-190","type":"journal-article","created":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T22:05:06Z","timestamp":1599861906000},"page":"888-895","source":"Crossref","is-referenced-by-count":5,"title":["Prognostic Impact of B-Type Natriuretic Peptide on Long-Term Clinical Outcomes in Patients with Non-ST-Segment Elevation Acute Myocardial Infarction Without Creatine Kinase Elevation"],"prefix":"10.1536","volume":"61","author":[{"given":"Norihito","family":"Takahashi","sequence":"first","affiliation":[{"name":"Department of Cardiology, Juntendo University Shizuoka Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Ogita","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Juntendo University Shizuoka Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Suwa","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Juntendo University Shizuoka Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Nakao","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Saiseikai Kumamoto Hospital Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukio","family":"Ozaki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fujita Health University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Kimura","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Yokohama City University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Ako","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kitasato University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruo","family":"Noguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuteru","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, National Hospital Organization Kumamoto Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuharu","family":"Nakama","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Hiroshima City Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Morita","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Osaka General Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Nippon Medical School Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiko","family":"Saito","sequence":"additional","affiliation":[{"name":"First Department of Internal Medicine, Nara Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Hirohata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The Sakakibara Heart Institute of Okayama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ogaki Municipal Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teruo","family":"Inoue","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Dokkyo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsunori","family":"Okamura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sakurabashi Watanabe Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Mano","sequence":"additional","affiliation":[{"name":"Cardiovascular Center, Kansai Rosai Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhito","family":"Hirata","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Okinawa Chubu Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Tanabe","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Mitsui Memorial Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshisato","family":"Shibata","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Miyazaki Medical Association Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mafumi","family":"Owa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Suwa Red Cross Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Tsujita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Funayama","sequence":"additional","affiliation":[{"name":"Department of Integrated Medicine, Saitama Medical Center Jichi Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuaki","family":"Kokubu","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular, Renal and Metabolic Medicine, Sapporo Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Kozuma","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Teikyo University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Uemura","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kawasaki Medical School"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Tobaru","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Sakakibara Heart Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keijiro","family":"Saku","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Fukuoka University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Oshima","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Gunma Prefectural Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunihiro","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Epidemiologic Informatics, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Epidemiologic Informatics, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisao","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Preventive Medicine and Epidemiologic Informatics, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaharu","family":"Ishihara","sequence":"additional","affiliation":[{"name":"Division of Coronary Artery Disease, Hyogo College of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of J-MINUET investigators","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Prabhu SD, Frangogiannis NG. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ Res 2016; 119: 91-112.","DOI":"10.1161\/CIRCRESAHA.116.303577"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Travers JG, Kamal FA, Robbins J, Yutzey KE, Blaxall BC. Cardiac fibrosis: the fibroblast awakens. Circ Res 2016; 118: 1021-40.","DOI":"10.1161\/CIRCRESAHA.115.306565"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339: 321-8.","DOI":"10.1056\/NEJM199807303390507"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Niu JM, Ma ZL, Xie C, Zhang ZQ. Association of plasma B-type natriuretic peptide concentration with myocardial infarct size in patients with acute myocardial infarction. Genet Mol Res 2014; 13: 6177-83.","DOI":"10.4238\/2014.February.21.6"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Garcia-Alvarez A, Sitges M, Delgado V, <i>et al<\/i>. Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance. Am J Cardiol 2009; 104: 878-82.","DOI":"10.1016\/j.amjcard.2009.05.025"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Mega JL, Morrow DA, De Lemos JA, <i>et al<\/i>. B-type natriuretic peptide at presentation and prognosis in patients with ST-segment elevation myocardial infarction: an ENTIRE-TIMI-23 substudy. J Am Coll Cardiol 2004; 44: 335-9.","DOI":"10.1016\/j.jacc.2004.04.033"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Morrow DA, Scirica BM, Sabatine MS, <i>et al<\/i>. B-type natriuretic peptide and the effect of ranolazine in patients with non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With ranolazine for less ischemia in non-ST Elevation Acute Coronary-Thrombolysis in myocardial infarction 36) trial. J Am Coll Cardiol 2010; 55: 1189-96.","DOI":"10.1016\/j.jacc.2009.09.068"},{"key":"8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000375398","volume":"131","year":"2015","unstructured":"8. Pesaro AE, Katz M, Caixeta A, <i>et al<\/i>. Prognostic value of serial brain natriuretic peptide measurements in patients with acute myocardial infarction. Cardiology 2015; 131: 116-21.","journal-title":"Cardiology","ISSN":"http:\/\/id.crossref.org\/issn\/0008-6312","issn-type":"print"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Sadanandan S, Cannon CP, Chekuri K, <i>et al<\/i>. Association of elevated B-type natriuretic peptide levels with angiographic findings among patients with unstable angina and non-ST-segment elevation myocardial infarction. J Am Coll Cardiol 2004; 44: 564-8.","DOI":"10.1016\/j.jacc.2004.03.072"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Scirica BM, Sabatine MS, Jarolim P, <i>et al<\/i>. Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial. Eur Heart J 2011; 32: 697-705.","DOI":"10.1093\/eurheartj\/ehq468"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Garc\u00eda-Alvarez A, Regueiro A, Hern\u00e1ndez J, <i>et al<\/i>. Additional value of B-type natriuretic peptide on discrimination of patients at risk for mortality after a non-ST-segment elevation acute coronary syndrome. Eur Heart J Acute Cardiovasc Care 2014; 3: 132-40.","DOI":"10.1177\/2048872614520753"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Fox KA, Goodman SG, Klein W, <i>et al<\/i>. Management of acute coronary syndromes. Variations in practice and outcome; findings from the Global Registry of Acute Coronary Events (GRACE). Eur Heart J 2002; 23: 1177-89.","DOI":"10.1053\/euhj.2001.3081"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Hasdai D, Behar S, Wallentin L, <i>et al<\/i>. A prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin; the euro Heart Survey of Acute Coronary Syndromes (euro Heart Survey ACS). Eur Heart J 2002; 23: 1190-201.","DOI":"10.1053\/euhj.2002.3193"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. McManus DD, Gore J, Yarzebski J, Spencer F, Lessard D, Goldberg RJ. Recent trends in the incidence, treatment, and outcomes of patients with STEMI and NSTEMI. Am J Med 2011; 124: 40-7.","DOI":"10.1016\/j.amjmed.2010.07.023"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Chan MY, Sun JL, Newby LK, <i>et al<\/i>. Long-term mortality of patients undergoing cardiac catheterization for ST-elevation and non-ST-elevation myocardial infarction. Circulation 2009; 119: 3110-7.","DOI":"10.1161\/CIRCULATIONAHA.108.799981"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ishihara M, Nakao K, Ozaki Y, <i>et al<\/i>. Long-term outcomes of non-ST-elevation myocardial infarction without creatine kinase elevation- the J-MINUET study. Circ J 2017; 81: 958-65.","DOI":"10.1253\/circj.CJ-17-0033"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ishihara M, Fujino M, Ogawa H, <i>et al<\/i>. Clinical presentation, management and outcome of Japanese patients with acute myocardial infarction in the troponin era - Japanese Registry of Acute Myocardial Infarction Diagnosed by universal definition (J-MINUET) -. Circ J 2015; 79: 1255-62.","DOI":"10.1253\/circj.CJ-15-0217"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Thygesen K, Alpert JS, Jaffe AS, <i>et al<\/i>. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012; 60: 1581-98.","DOI":"10.1016\/j.jacc.2012.08.001"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Authors\/Task Force Members, McMurray JJ, Adamopoulos S, <i>et al<\/i>. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33: 1787-847.","DOI":"10.1093\/eurheartj\/ehs104"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Daida H, Miyauchi K, Ogawa H, <i>et al<\/i>. Management and two-year long-term clinical outcome of acute coronary syndrome in Japan: prevention of atherothrombotic incidents following ischemic coronary attack (PACIFIC) registry. Circ J 2013; 77: 934-43.","DOI":"10.1253\/circj.CJ-13-0174"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lee TH, Goldman L. Serum enzyme assays in the diagnosis of acute myocardial infarction. Recommendations based on a quantitative analysis. Ann Intern Med 1986; 105: 221-33.","DOI":"10.7326\/0003-4819-105-2-221"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Dohi T, Maehara A, Brener SJ, <i>et al<\/i>. Utility of peak creatine kinase-MB measurements in predicting myocardial infarct size, left ventricular dysfunction, and outcome after first anterior wall acute myocardial infarction (from the INFUSE-AMI trial). Am J Cardiol 2015; 115: 563-70.","DOI":"10.1016\/j.amjcard.2014.12.008"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Suzuki S, Yoshimura M, Nakayama M, <i>et al<\/i>. Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis. Circulation 2004; 110: 1387-91.","DOI":"10.1161\/01.CIR.0000141295.60857.30"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Wolsk E, Claggett B, Pfeffer MA, <i>et al<\/i>. Role of B-type natriuretic peptide and N-terminal prohormone BNP as predictors of cardiovascular morbidity and mortality in patients with a recent coronary event and type 2 diabetes mellitus. J Am Heart Assoc 2017; 6: e004743.","DOI":"10.1161\/JAHA.116.004743"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Morrow DA, de Lemos JA, Sabatine MS, <i>et al<\/i>. Evaluation of B-type natriuretic peptide for risk assessment in unstable Angina\/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol 2003; 41: 1264-72.","DOI":"10.1016\/S0735-1097(03)00168-2"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Morita E, Yasue H, Yoshimura M, <i>et al<\/i>. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 1993; 88: 82-91.","DOI":"10.1161\/01.CIR.88.1.82"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Lee JW, Choi E, Khanam SS, <i>et al<\/i>. Prognostic value of short-term follow-up B-type natriuretic peptide levels after hospital discharge in patients with acute myocardial infarction. Int J Cardiol 2019; 289: 19-23.","DOI":"10.1016\/j.ijcard.2019.01.026"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. de Lemos JA, Morrow DA. Use of natriuretic peptides in clinical decision-making for patients with non-ST-elevation acute coronary syndromes. Am Heart J 2007; 153: 450-3.","DOI":"10.1016\/j.ahj.2007.02.012"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Hogenhuis J, Voors AA, Jaarsma T, <i>et al<\/i>. Anaemia and renal dysfunction are independently associated with BNP and NT-proBNP levels in patients with heart failure. Eur J Heart Fail 2007; 9: 787-94.","DOI":"10.1016\/j.ejheart.2007.04.001"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Desai AS, Toto R, Jarolim P, <i>et al<\/i>. Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD. Am J Kidney Dis 2011; 58: 717-28.","DOI":"10.1053\/j.ajkd.2011.05.020"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Amsterdam EA, Wenger NK, Brindis RG, <i>et al<\/i>. 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Circulation 2014; 130: 2354-94.","DOI":"10.1161\/CIR.0000000000000133"},{"key":"32","unstructured":"32. Guidelines for management of acute coronary syndrome without persistent ST Segment Elevation <i>The Japanese Circulation Society<\/i>; 2012. Available at: http:\/\/www.j-circ.or.jp\/guideline\/. Accessed March 31, 2018."}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/5\/61_20-190\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T03:56:52Z","timestamp":1601697412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/61\/5\/61_20-190\/_article"}},"subtitle":["A Japanese registry of acute Myocardial INfarction diagnosed by Universal dEfiniTion (J-MINUET) Substudy"],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.20-190","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"type":"print","value":"1349-2365"},{"type":"electronic","value":"1349-3299"}],"subject":[],"published":{"date-parts":[[2020,9,29]]}}}